Rouen-based medtech startup Robocath designs, develops, and commercializes cardiovascular robotic systems for the treatment of vascular diseases such as heart attack and stroke. The startup has raised €5 million to support the rollout of its robotic platform in strategic European target markets. The company has also hired Lucien Goffart as CEO.
We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.
AI Alzheimer antibodies bacteria binx health Biosimilar Blood Filter Cancer cardiovascular cell therapy CE Mark clinical trial colorectal cancer Diagnostics Digital Health Drug Discovery ExThera Medical FDA FDA approval funding fundraising glycosylation Halodoc HIV Innovation Licensing M&A medical device medtech microbial microbial DNA microbial RNA microbiome Neuro Novartis pharma Pharming Prescient Metabiomics robots software Therapeutics Therapy USA VIrology women health